OICR researchers

OICR supports approximately 1,800 researchers at institutions across the province of Ontario. This page lists the recipients of OICR Investigator Awards, Associates, research fellows and the leaders of OICR’s research programs and initiatives. Find out more about OICR’s Investigator Awards Program.

Jump to last name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Laurie Ailles

Dr. Ailles and her team are focusing on two major research areas, intra-tumoural heterogeneity and epigenetics in clear cell renal cell carcinoma (ccRCC).

More details

Rima Al-awar

The goal of the Drug Discovery group is to optimize lead molecules and progress them to drug candidates that can translate into therapeutic benefits to cancer patients.

More details

Ken Aldape

Dr. Aldape is a neuropathologist and laboratory scientist with research interests in brain tumours and cancer genomics in general.

More details

Philip Awadalla

Dr. Awadalla and his team focuses on next-generation genomics approaches, model-based tools and population-based approaches to study cancer.

More details

John Bartlett

Dr. Bartlett is developing new diagnostic approaches to improve patient diagnosis and treatment.

More details

Philippe Bedard

Dr. Bedard is Co-Principal Investigator of the Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE) study.

More details

John Bell

Dr. Bell’s lab has shown that a variety of viruses selectively replicate in and kill cancer cell lines while leaving healthy parts of the body intact.

More details

Paul Boutros

Dr. Boutros' team uses biological big data to create new biomarkers that personalize therapy for individual patients.

More details

Marcus Butler

Dr. Butler is Co-leader of OICR's Immuno-oncology Translational Research Initiative (ACTION).

Janet Dancey

Dr. Janet Dancey is the leader of the Canadian Cancer Clinical Trials Network (3CTN) and the Canadian Cancer Trials Group (CCTG)

More details

John Dick

Dr. Dick’s world-renowned research program centers on the theme that genetic and non-genetic determinants of tumour heterogeneity are linked through stemness.

More details

Peter Dirks

Dr. Dirks is Co-leader of OICR's Brain Cancer Translational Research Initiative.

Harriet Feilotter

Dr. Feilotter focuses on the development of biomarkers to be used in the screening, diagnosis or treatment of human diseases, including cancer.

More details

Aaron Fenster

Dr. Fenster is driven by the opportunity to use technological innovations to meet the challenges of cancer diagnosis and therapy needs.

More details

Marc Fiume

Dr. Fiume is an OICR associate researcher.

More details

Vincent Ferretti

Dr. Ferretti’s expertise is in bioinformatics with experience in both large-scale software development and computational genomics.

More details →

Geoffrey T. Fong

Dr. Fong is the founder of the International Tobacco Control Policy Evaluation Project. This project's objective is to evaluate the impact of policies designed to control tobacco use.

More details

Steven Gallinger

Dr. Gallinger is Leader of OICR's Pancreatic Cancer Translational Research Initiative (PanCuRx).

More details

Eva Grunfeld

The focus of Dr. Grunfeld’s research is the evaluation of access to and quality of cancer care across the cancer control continuum – from screening to end-of-life care.

More details

Benjamin Haibe-Kains

Dr. Haibe-Kains is an OICR associate researcher.

More details

Masoom Haider

Dr. Haider’s research focus is abdominal and pelvic MRI with an interest in therapeutic response assessment and quantitative imaging of cancer.

More details

Timothy Hanna

Dr. Hanna’s research focuses on three translational streams of health services research: quality of care, value of care and access to care.

More details

Naoto Hirano

The overarching goal of Dr. Hirano’s research is to devise novel anti-tumour immunotherapeutic modalities that can cure cancer.

More details

Kristin Hope

Dr. Hope aims to identify the underlying processes that lead to the transformation of healthy cells into leukemic cells and contribute to the progression of the disease.

More details

Tamara Jamaspishvili

Dr. Jamaspishvili’s research interest and project goals are to identify and validate promising diagnostic and prognostic biomarkers for early prostate cancer.

More details

Elizabeth Kornaga

Dr. Kornaga is an OICR associate researcher.

More details

David LeBrun

Dr. LeBrun’s research group studies perturbations in the regulation of gene transcription that underlie acute lymphoblastic leukemia.

More details

Mathieu Lupien

Dr. Lupien’s research highlights the need to characterize and understand the role of noncoding regulatory elements as targets of genetic and epigenetic changes in oncogenesis.

More details

John McPherson

Dr. McPherson is an OICR associate researcher specializing in genome technologies.

More details

Brian Nieman

Dr. Nieman is studying the developmental impact of chemotherapy agents with a goal of improved brain development and quality of life in childhood cancer patients.

More details

Faiyaz Notta

Dr. Notta is an OICR associate researcher.

Amit Oza

Dr. Oza is Co-leader of OICR's Ovarian Cancer Translational Research Initiative.

David Palma

Dr. Palma's research focuses on new imaging technologies used with radiotherapy to improve tumour targeting and to deliver higher doses of radiotherapy than previously possible.

More details

Bret Pearson

Dr. Pearson’s lab is trying to understand the connection between adult stem cells and cancer by using the freshwater planarian as an in vivo model system.

More details

Gregory Pond

Dr. Pond’s research interest is in statistical methodologies and analysis of cancer clinical trials, with an aim to facilitate the translation of scientific discoveries into the clinic.

More details

Trevor Pugh

Dr. Pugh is Director of the Princess Margaret-OICR Translational Genomics Laboratory and an OICR associate researcher.

Jüri Reimand

The Reimand Lab develops and applies methods to interpret cancer data using pathway and network information.

More details

Robert Rottapel

The Rottapel laboratory uses functional genetic screens (both shRNA and CRISPR/Cas9) to identify novel vulnerabilities in ovarian cancer as a strategy to develop new therapeutic targets.

More details

Aaron Schimmer

Dr. Schimmer is Co-leader of OICR's Acute Leukemia Translational Research Initiative.

More details

Timothy Scholl

Dr. Scholl is focusing on developing an emergent technique for molecular imaging with magnetic resonance

More details

Jared Simpson

The Simpson lab develops algorithms and software for the analysis of high-throughput sequencing data.

More details

Lillian Siu

Dr. Siu is Co-Principal Investigator of the Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE) study.

More details

Lincoln Stein

Dr. Stein is Head of Adaptive Oncology at OICR. His research focuses on using network and pathway-based analysis to identify common mechanisms in multiple cancer types and to devise prognostic and predictive signatures.

More details

Michael Taylor

Dr. Taylor is Co-leader of OICR's Brain Cancer Translational Research Initiative.

More details

Brad Wouters

Dr. Wouters’ lab has identified new signaling pathways that influence how tumours respond to environments with reduced oxygenation.

More details

Martin Yaffe

Dr. Yaffe’s research is directed toward development and improvement of imaging techniques for the earlier detection, diagnosis and treatment of cancer

More details

Christina Yung

Director, Genome Informatics

More details